Product Focus - COVID-19

March 24, 2021

Since SARS-CoV-2 began spreading around the world in 2020, companies have developed a range of products to address large-scale diagnostic- and surveillance-testing needs.

Rapid RT PCR test

The rapid RT-PCR test for SARS-CoV-2 features a disposable cartridge with all reagents included, providing results in 17 minutes or less. The test runs on the FINDER 1.5, which is a toaster-sized instrument powered by digital microfluidics, without pumps, tubing, or valves.


Run Controls

The SARS-CoV-2, Flu, RSV Positive and Negative Run Controls are unassayed external controls used to monitor the presence or absence of SARS-CoV-2, Influenza A, Influenza B and RSV (A). The products are formulated in a synthetic matrix and contain human genomic DNA.

Bio-Rad Laboratories

Molecular diagnostics

The Aptima SARS-CoV-2 assay is a molecular diagnostic test that utilizes proprietary TMA (Transcription-Mediated Amplification) technology to detect RNA from SARS-CoV-2. Meanwhile, the Panther Fusion SARS-CoV-2 real-time PCR assay also detects RNA from SARS-CoV-2. Both tests process 1,000 tests in 24 hours and deliver results in 3.5 hours or less.


Quality tool

AccuPlex SARS-CoV-2 in synthetic oral fluid is a research tool for developers creating saliva-based SARS-CoV-2 assays, as well as a complete quality solution for clinical laboratories employing such tests. The product includes positive vials containing the full SARS-CoV-2 viral genome, and human RNase P sequences to monitor sample collection.


RT-PCR test

The QIAstat-Dx Analyzer, combined with QIAstat-Dx assay cartridges, uses real-time RT-PCR to detect multiple respiratory pathogens in about an hour. The QIAstat-Dx Analyzer and cartridges are designed as a closed system that contains on board all necessary reagents, enabling an easy-to-use workflow.


Third party control

The Acusera SARS-CoV-2 Antibody Control comprises both reactive and non-reactive controls for Anti SARS-CoV-2, supporting assay validation and routine performance monitoring of serological assays for COVID-19. The control, which is CE marked, is supplied in a liquid format with a 30-day open vial stability.


Variant detection

The high-throughput Allplex 2019-nCoV Assay (FDA EUA) detects 3 different target genes (E, RdRP, and N) of SARS-CoV-2 and covers multiple variants in a single reaction tube. The test provides results within 1 hour and 50 minutes. It is designed for maximum throughput to accommodate high volume testing.

Seegene Technologies


The Heratherm Advanced Protocol Security Microbiological Incubator enables reliable heat virus inactivation to protect medical laboratory personnel from infection and allow safe sample handling. It offers temperature uniformity, continuous operation, and a sterile environment for sample protection and reliable results.

Thermo Fisher Scientific

Foam swab

The specialty swab includes an applicator tipped with 100ppi medical grade polyurethane foam with high particle collection capacity and sturdy handle for control. Used widely for COVID-19 testing, the swab also can be used for various medical, diagnostic, and DNA testing applications.

Puritan Medical Products

Automated PCR test

The cobas SARS-CoV-2 Test is intended for the qualitative detection of SARS-CoV-2 in nasal, nasopharyngeal and oropharyngeal swab samples from patients with suspected COVID-19 infection. Laboratories can run the PCR test on the automated, high-throughput cobas 6800/8800 systems, which provide results in about three hours.

Roche Diagnostics